Sacred Plants and Mental Health in Latin America

Authors

  • M.Sc. Oscar Espin European Institute for Multidisciplinary Studies on Human Rights and Science - Knowmad Institut
  • Rev. Martin Díaz European Institute for Multidisciplinary Studies on Human Rights and Science - Knowmad Institut https://orcid.org/0000-0001-5162-4786

DOI:

https://doi.org/10.5281/zenodo.7235793

Abstract

Sacred plants have a number of phenomena that revolve around their ritual and medicinal use, as well as being seen as carrying a bond with the sphere of the sacred. México is the country that has the greatest diversity of sacred plants in the Americas because its indigenous groups have a magical-religious relationship with them. In the beginning of the study of sacred plants, psilocybin, mescaline and ergotamine began to be classified as classical psychedelics, this categorization was of great help to psychiatry and neuroscience in the 1950s and 1960s.

Author Biography

M.Sc. Oscar Espin, European Institute for Multidisciplinary Studies on Human Rights and Science - Knowmad Institut

Master of Science on Public Mental Health from the National Autonomous University of Mexico (2020), he is also a Social Anthropologist from the National School of Anthropology and History (2012).
He currently develops qualitative research in mental health, specifically working directly with people who use psychoactive substances, both in controlled clinical settings, groups and associations of mutual aid, as well as in recreational contexts where there is substance consumption.

References

➔ Anderson T, Petrankerz R, Rosenbaum D, Weissman C, Williams A, Huis, K, Hapkes E, (2018). Microdosing psychedelics:personality, mental health and creativity, differences in microdosers. Journal of Psychopharmacology.

➔ Barone W. Beck j & Mitsunaga-Whitten. (2019). Perceived benefits of MDMA – Assiste psychotherapy beyond symptom reduction: qualittaive follow -uo study of a clinical trial for individual with treatment- resistan PTSD. Journal of Psychoactive Drugs. 2019 March 8. Doi:10.1080/02791072.2019.1580805

➔ Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M., Erritzoe, D., Kaelen, M., et al. (2016). Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study. The Lancet Psychiatry, 3(7), 619-627. doi:10.1016/S2215-0366(16)30065-7

➔ De Gregorio, Enns, Nuñez, Posa & Gobbi. (2018). D-Lysergic acid diethylamide, psilocybin and other classic hallucinogens: Mechanism of action and potential therapeutic applications in modo disorders. Progress in Brain Research. Elsevier

➔ Eliade Mircea (1998). Sagrado y profano. Barcelona, Paidos.

➔ European Monitoring Centre for Drugs and Drug Addiction. (2016). European Drug Report 2016: Trends and Developments. Publications Office of the European Union, Luxembourgp

➔ Johnson, MW, Hendricks,PS, Barret FS, Griffiths,RR. (2018). Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Pharmacology & Therapeutics Journal, December 4, 2018.

➔ Samorini,G. (2001). Los alucinógenos en el mito. La Liebre de Marzo. Barcelona

➔ Schultes R.E & Hofmann A. (1983). Plantas de los dioses: Orígenes del uso de los alucinogenos. Fonde de Cultura Económica. México ➔ Organización Mundial de la Salud. (2004). Invertir en salud mental. Ginebra. Suiza.

➔ United Nations (2015) Transforming our world: The 2030 agenda of sustainable development. Geneve. Switzerland

➔ World Health Organization (2013). Investing in mental health: Evidence for action. Geneve,Switzerland.

Sacred Plants

Downloads

Published

2019-05-22

How to Cite

Espin García, O. H., & Díaz Velásquez, M. I. (2019). Sacred Plants and Mental Health in Latin America. Journal of Multidisciplinary Studies in Human Rights and Science, 1(1-4). https://doi.org/10.5281/zenodo.7235793

Issue

Vol. 1 No. 1-4 (2019): Drug Policy, Novel Foods and the Medicalization of Death

Section

Articles

Categories

URN

http://nbn-resolving.de/urn:nbn:de:101:1-2022102117125397974503

License

Copyright (c) 2019 M.Sc. Oscar Espin

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All authors who publish their work in this journal give their patrimonial rights in favor of the JMSHRS on a non-exclusive basis. This means that authors may enter into other independent and contractual agreements to disseminate their text published in this journal. Such as, for example, including it in an institutional, thematic or other repository, publishing it in a book, or other digital or physical media, as long as they explicitly indicate that the work was first published in this journal.

The responsibility for the content of each published work corresponds exclusively to the authors themselves, excluding the editors from any legal responsibility.

The contents of the journal will be disseminated under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). All issues are open access (OA) from the moment of publication.